Agios Pharmaceuticals AGIO Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 90%+1.8pp | 88.3%+1.0pp | 87.2%-1.0pp | 88.2%+0.7pp | 87.5%-1.1pp | |
| Operating margin | -720%+154pp | -873.9%+188pp | -1,061.8%+67.3pp | -1,129.1%+59.7pp | -1,188.9%-22.4pp | |
| Net margin | -639.8%+124pp | -764%— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | -32.8%-2.6pp | -30.2%— | —— | —— | —— | |
| Return on invested capital | -38.5%-3.1pp | -35.4%+0.2pp | -35.6%+11.0pp | -46.7%-5.4pp | -41.3%-4.5pp | |
| Efficiency | ||||||
| Asset turnover | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Liquidity | ||||||
| Current ratio | 14.2×+2.7× | 11.5×-2.4× | 13.8×-0.7× | 14.5×-4.0× | 18.5×+6.6× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $18.87-8.3% | $20.58-6.8% | $22.09-6.6% | $23.64-7.4% | $25.52-4.1% | |
| Valuation | ||||||
| Market capitalization | $1.98B+24.9% | $1.59B-31.9% | $2.33B+20.5% | $1.94B+15.3% | $1.68B-10.4% | |
| Price / sales | 30×+0.6× | 29.4×-22.7× | 52.1×+4.7× | 47.4×+2.0× | 45.3×-6.0× | |
| Price / book | 1.8×+0.5× | 1.3×-0.5× | 1.8×+0.4× | 1.4×+0.3× | 1.1×-0.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Agios Pharmaceuticals's profit margins?
- Agios Pharmaceuticals (AGIO) runs a 90.0% gross margin and a -720.0% operating margin, with a -639.8% net margin.
- Where do Agios Pharmaceuticals's ratios come from?
- Every ratio is computed from Agios Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
